lundi, 04 juin 2018 13:47

ENYO Pharma raises €40 million

Written by 
Rate this item
(0 votes)

ENYO Pharma, a clinical stage biotech company developing innovative drug candidates by mimicking virus strategies to modulate host cellular functions, today announced that it has completed a €40 million Series B round of financing from US and European investors

Read 410 times Last modified on mardi, 05 juin 2018 15:39